Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Eryn Callihan

Concepts (51)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pregnancy Complications, Neoplastic
1
2013
53
0.400
Why?
Carcinoma, Ductal, Breast
1
2013
82
0.390
Why?
Postpartum Period
2
2022
331
0.370
Why?
Breast Neoplasms
2
2022
2142
0.260
Why?
Neoplasm Invasiveness
1
2024
481
0.200
Why?
Cisplatin
1
2024
298
0.190
Why?
Neoadjuvant Therapy
1
2024
382
0.190
Why?
Urinary Bladder Neoplasms
1
2024
227
0.180
Why?
Carcinoma, Renal Cell
1
2023
180
0.180
Why?
Prostate-Specific Antigen
1
2021
162
0.170
Why?
Kidney Neoplasms
1
2023
350
0.160
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1565
0.120
Why?
Proportional Hazards Models
2
2022
1201
0.120
Why?
Prostatic Neoplasms
1
2021
1016
0.110
Why?
Myeloid Cells
1
2013
143
0.100
Why?
Lymphatic Metastasis
1
2013
318
0.100
Why?
Kaplan-Meier Estimate
1
2013
857
0.090
Why?
Risk
1
2013
854
0.080
Why?
Prognosis
2
2022
3791
0.080
Why?
Lymphocyte Activation
1
2013
1106
0.080
Why?
Multivariate Analysis
1
2013
1500
0.080
Why?
Melanoma
1
2013
729
0.070
Why?
Pregnancy
2
2022
6384
0.060
Why?
T-Lymphocytes
1
2013
1928
0.060
Why?
Vinblastine
1
2024
69
0.060
Why?
Cystectomy
1
2024
38
0.050
Why?
Deoxycytidine
1
2024
163
0.050
Why?
Chemotherapy, Adjuvant
1
2024
381
0.050
Why?
Methotrexate
1
2024
249
0.050
Why?
Doxorubicin
1
2024
325
0.050
Why?
Parity
1
2022
120
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2023
758
0.040
Why?
Biopsy
1
2021
1087
0.040
Why?
Humans
6
2024
129212
0.030
Why?
Aged, 80 and over
2
2021
7061
0.030
Why?
Retrospective Studies
1
2013
14488
0.030
Why?
Mass Screening
1
2021
1147
0.030
Why?
Blood Cell Count
1
2013
52
0.030
Why?
Adult
2
2013
35464
0.030
Why?
Female
3
2022
68600
0.030
Why?
Lipopolysaccharide Receptors
1
2013
87
0.030
Why?
Cohort Studies
1
2022
5408
0.020
Why?
T-Lymphocytes, Regulatory
1
2013
375
0.020
Why?
Survival Analysis
1
2013
1271
0.020
Why?
Neoplasm Staging
1
2013
1292
0.020
Why?
Flow Cytometry
1
2013
1156
0.020
Why?
Aged
2
2021
22030
0.020
Why?
Middle Aged
2
2022
31075
0.020
Why?
Disease Progression
1
2013
2622
0.020
Why?
Male
2
2021
63491
0.010
Why?
Young Adult
1
2013
12396
0.010
Why?
Callihan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)